ARTICLE | Company News
Sanofi licenses Atrix's Leuprogel
January 9, 2001 8:00 AM UTC
ATRX granted Sanofi- Synthelabo (Paris, France) an exclusive North American marketing license to its Leuprogel leuprolide gonadotropin-releasing hormone (GnRH) agonist in the Atrigel biodegradable pol...